Cargando…

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses

The SARS-CoV-2 Delta variant is currently responsible for most infections worldwide, including among fully vaccinated individuals. Although these latter infections are associated with milder COVID-19 disease relative to unvaccinated subjects, the specificity and durability of antibody responses elic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walls, Alexandra C., Sprouse, Kaitlin R., Joshi, Anshu, Bowen, John E., Franko, Nicholas, Navarro, Mary Jane, Stewart, Cameron, McCallum, Matthew, Goecker, Erin A., Degli-Angeli, Emily J., Logue, Jenni, Greninger, Alex, Chu, Helen, Veesler, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687475/ https://www.ncbi.nlm.nih.gov/pubmed/34931192 http://dx.doi.org/10.1101/2021.12.08.471707

Ejemplares similares

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2022)

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
por: Seow, Jeffrey, et al.
Publicado: (2023)

Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
por: Bowen, John E., et al.
Publicado: (2022)

Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation
por: McCallum, Matthew, et al.
Publicado: (2020)

SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
por: Bowen, John E., et al.
Publicado: (2022)

Closing coronavirus spike glycoproteins by structure-guided design
por: McCallum, Matthew, et al.
Publicado: (2020)

Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
por: Bowen, John E., et al.
Publicado: (2022)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2021)

SARS-CoV-2 spike conformation determines plasma neutralizing activity
por: Bowen, John E., et al.
Publicado: (2021)

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2022)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond
por: Kwon, Hyung-Joon, et al.
Publicado: (2022)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
por: Lechmere, Thomas, et al.
Publicado: (2022)

Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
por: Zhu, Ka-Li, et al.
Publicado: (2023)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters
por: Berry, Catherine, et al.
Publicado: (2023)

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2022)

Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
por: Takano, Tomohiro, et al.
Publicado: (2023)

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2023)

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
por: Low, Jun Siong, et al.
Publicado: (2022)

Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
por: Addetia, Amin, et al.
Publicado: (2022)

Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
por: Addetia, Amin, et al.
Publicado: (2023)

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern
por: Komori, Mai, et al.
Publicado: (2023)

Structural basis for broad coronavirus neutralization
por: Sauer, Maximilian M., et al.
Publicado: (2021)

Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2023)

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
por: Greaney, Allison J., et al.
Publicado: (2021)

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
por: Greaney, Allison J., et al.
Publicado: (2022)

A fatal case of COVID‐19 breakthrough infection due to the delta variant
por: Bignardi, Elio, et al.
Publicado: (2022)

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
por: Guan, Xiaoqing, et al.
Publicado: (2023)

Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection
por: Zang, Jinkai, et al.
Publicado: (2021)

Investigation of vaccine breakthrough infections by vaccination scheme during the Delta variant wave in France
por: Bal, Antonin, et al.
Publicado: (2022)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
por: Zou, Jing, et al.
Publicado: (2022)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

2079. Maternal hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection alone
por: LaCourse, Sylvia M, et al.
Publicado: (2023)

Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine
por: Novak, Hayley, et al.
Publicado: (2021)

Designer antigens for elicitation of broadly neutralizing antibodies against HIV
por: Kok, Tuckweng, et al.
Publicado: (2014)

Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows
por: Sok, Devin, et al.
Publicado: (2017)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
por: Ahmed, Yousuf, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_71jr1en8qgas7jjcrcc9bt6g0i